Company: TDBCP
Filing Date: 2025-08-29
Form Type: 424B2
Source: 0001140361-25-033346
Chunk: 9

Company: TORONTO DOMINION BANK
Filing Date: 2025-08-29
Form: 424B2
Chunk 9
---
Material U.S. Federal Income Tax Consequences — Alternative Treatments”. You should consult 
 your tax advisors as to the tax consequences of an investment in the notes and the potential alternative treatments.                                                                                                                             |

| ◾ | For a discussion of the Canadian federal income tax consequences of investing in the notes, please see the discussion in the prospectus under “Tax Consequences — Canadian Taxation” and in the product supplement EQUITY ARN-1 under           
 “Supplemental Discussion of Canadian Tax Consequences” and the further discussion herein under “Summary of Canadian Federal Income Tax Consequences”. If you are not a Non-resident Holder (as that term is defined in the prospectus) for      
 Canadian federal income tax purposes or if you acquire the notes in the secondary market, you should consult your tax advisors as to the consequences of acquiring, holding and disposing of the notes and receiving the payments that might be 
 due under the notes.                                                                                                                                                                                                                            |

Other Terms of the Notes Market Measure Business Day The following definition shall supersede and replace the definition of a “Market Measure Business Day” set forth in product supplement EQUITY ARN-1. A “Market Measure Business Day” means a day on which: (A) the Eurex (or any successor) is open for trading; and (B) the Index or any successor thereto is calculated and published.

| Accelerated Return Notes® | TS-7 |

| Accelerated Return Notes®                            
 Linked to the EURO STOXX 50®Index due November, 2026 |

The Index All disclosures contained in this term sheet regarding the Index, including, without limitation, its make-up, method of calculation, and changes in its components, have been derived from publicly available sources. The information reflects the policies of, and is subject to change by, STOXX Limited (“STOXX” or the “Index sponsor”) .The Index sponsor, which licenses the copyright and all other rights to the Index, has no obligation to continue to publish, and may discontinue publication of, the Index. The consequences of the Index sponsor discontinuing publication of the Index are discussed in the section entitled “Description of ARNs — Discontinuance of an Index” beginning on page PS-27 of product supplement EQUITY ARN-1. None of us, our affiliates, the calculation agents, MLPF&S or BofAS has independently verified the accuracy or completeness of any information obtained with respect to the Index nor accepts any responsibility for the calculation, maintenance or